Rubra Medicaments Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 1 million compared to INR 1.25 million a year ago. Net income was INR 0.011 million compared to INR 0.184 million a year ago. Basic eps was INR 0 compared to INR 0.03 a year ago. For the nine months, total revenue was INR 1.875 million compared to INR 3.576 million a year ago. Net income was INR 0.012 million compared to INR 0.377 million a year ago. Basic eps was INR 0 compared to INR 0.07 a year ago.